Navy General Hospital, Beijing
Clinical trials sponsored by Navy General Hospital, Beijing, explained in plain language.
-
New hope for hard-to-treat lymphoma: triple-drug attack tested in 80 patients
Disease control Not yet recruitingThis study tests a combination of three drugs (Glofitamab, Polatuzumab vedotin, and GemOx) as an initial treatment for people with aggressive B-cell lymphoma whose cancer did not respond to prior therapy or has returned. About 80 adults will take part to see if the combination is…
Phase: PHASE2 • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated May 17, 2026 07:02 UTC
-
Smartwatch study aims to predict and prevent AF complications
Disease control Not yet recruitingThis study tests whether using a smartwatch to continuously track atrial fibrillation (AF) patterns can help doctors decide the best time to start or change treatment. About 3,194 adults with paroxysmal AF will wear a smartwatch to measure their AF burden. If the burden is high, …
Phase: NA • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
10,000 smartwatch users to track AF burden and stroke risk in landmark study
Knowledge-focused Not yet recruitingThis study will follow 10,000 people with atrial fibrillation (AF) for two years to see if the total time they spend in AF (called AF burden) is linked to strokes and blood clots. Participants will use their own smartphones and smartwatches to track their heart rhythm. The goal i…
Sponsor: Navy General Hospital, Beijing • Aim: Knowledge-focused
Last updated May 17, 2026 07:01 UTC